Additionally, animal model experiment demonstrated that the overexpression of wild-type ezrin promotes breast cancer metastasis while expression of the dominant-negative amino-terminal ezrin domain markedly inhibits metastasis [14]. This evidence concerns the gene EZR and breast carcinoma.